Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Allurion TechnologiesALUR +14.29%23 3-1 Month Momentum % is -61.26% as of Sep. 09, 2026. GuruFocus rates ALUR with a GF Score™ of 23/100 and a GF Value™ of $10.24 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Allurion Technologies ranks worse than 98.24% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-09), Allurion Technologies's 3-1 Month Momentum % is -61.26%.
The industry rank for Allurion Technologies's 3-1 Month Momentum % or its related term are showing as below:
ALUR's 3-1 Month Momentum % is ranked worse than 98.24% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs ALUR: -61.26
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Allurion Technologies 3-1 Month Momentum % Related Terms
ALUR vs ESMC, LUDG, AEMD: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, Allurion Technologies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Allurion Technologies 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Allurion Technologies's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Allurion Technologies (ALUR) has a 3-1 Month Momentum % of -61.26% as of Sep. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Allurion Technologies and its competitors. According to the industry distribution chart, Allurion Technologies ranks #836 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 98.2%.
Is Allurion Technologies' 3-1 Month Momentum % too high?
Allurion Technologies' current 3-1 Month Momentum % is -61.26%. Based on the distribution chart, Allurion Technologies ranks #836 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Allurion Technologies has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' 3-1 Month Momentum % compare to ESMC and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Allurion Technologies ranks #836 out of 851 companies for 3-1 Month Momentum %. This places Allurion Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Allurion Technologies and its competitors. Allurion Technologies's current 3-1 Month Momentum % is -61.26%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALUR) is currently considered Possible Value Trap. The stock's GF Value™ is $10.24, compared to a current price of $1.28 — trading 87.5% below its estimated fair value. The current 3-1 Month Momentum % is -61.26%. Allurion Technologies' overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Allurion Technologies (ALUR), the current 3-1 Month Momentum % is -61.26% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Allurion Technologies (ALUR) Overvalued in 2026?
Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued.
The current stock price of $1.28 is trading 87.5% below its estimated GF Value™ of $10.24.
GuruFocus considers Allurion Technologies to be Possible Value Trap.
Key valuation signals for ALUR:
3-1 Month Momentum %: -61.26%
GF Value™: $10.24 vs. price of $1.28 (87.5% below fair value)
No single metric tells the full story. See the ALUR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
23GF Score
Get the complete analysis for ALUR
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALUR has been successfully added to your 
